Insider10% Owner
V N Biotech Target Insider Trading Activity
Every SEC Form 4 transaction reported by V N Biotech Target, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is V N Biotech Target buying or selling?
V N Biotech Target reported 64 open-market buys ($164.9M) and 1 sells ($845.8K) across 65 Form 4 filings at 4 companies — a net buying position of $164.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Nov 19, 2024)
Total Form 4 filings
65
SEC EDGAR
Companies
4
Buys (64)
$164.9M
Sells (1)
$845.8K
Insider sentiment
Net buyingNet insider flow of $164.0M in net buying, filed between May 22, 2018 – Nov 19, 2024.
Companies V N Biotech Target files for
Recent V N Biotech Target transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2024 | MTEM | 10% Owner | Sale | 1.3M | $845.8K | SEC ↗ |
| Apr 5, 2024 | MTEM | 10% Owner | Purchase | 250.0K | $587.5K | SEC ↗ |
| Oct 4, 2023 | MGNX | 10% Owner | Purchase | 150.0K | $669.6K | SEC ↗ |
| Sep 11, 2023 | MGNX | 10% Owner | Purchase | 200.0K | $1.1M | SEC ↗ |
| Jul 19, 2023 | MTEM | 10% Owner | Purchase | 4.3M | $2.0M | SEC ↗ |
| Feb 16, 2023 | MGNX | 10% Owner | Purchase | 500.0K | $2.5M | SEC ↗ |
| Jan 23, 2023 | MGNX | 10% Owner | Purchase | 150.0K | $794.9K | SEC ↗ |
| Dec 28, 2022 | MGNX | 10% Owner | Purchase | 400.0K | $2.3M | SEC ↗ |
| Nov 25, 2022 | MGNX | 10% Owner | Purchase | 300.0K | $1.8M | SEC ↗ |
| Oct 25, 2022 | MGNX | 10% Owner | Purchase | 500.0K | $2.2M | SEC ↗ |
| Oct 21, 2022 | MGNX | 10% Owner | Purchase | 454.4K | $1.8M | SEC ↗ |
| May 20, 2022 | RDUS | 10% Owner | Purchase | 477.8K | $2.7M | SEC ↗ |
| May 18, 2022 | MTEM | 10% Owner | Purchase | 200.0K | $236.2K | SEC ↗ |
| Jan 10, 2022 | MTEM | 10% Owner | Purchase | 200.0K | $807.2K | SEC ↗ |
| Jan 7, 2022 | RDUS | 10% Owner | Purchase | 550.0K | $3.5M | SEC ↗ |
| Nov 23, 2021 | MGNX | 10% Owner | Purchase | 200.0K | $3.7M | SEC ↗ |
| Oct 1, 2021 | RDUS | 10% Owner | Purchase | 100.0K | $1.3M | SEC ↗ |
| Sep 30, 2021 | MGNX | 10% Owner | Purchase | 200.0K | $4.1M | SEC ↗ |
| Sep 24, 2021 | RDUS | 10% Owner | Purchase | 150.0K | $1.8M | SEC ↗ |
| Sep 23, 2021 | MTEM | 10% Owner | Purchase | 750.0K | $4.5M | SEC ↗ |
| Sep 20, 2021 | MGNX | 10% Owner | Purchase | 600.0K | $12.4M | SEC ↗ |
| Sep 20, 2021 | MTEM | 10% Owner | Purchase | 100.0K | $613.0K | SEC ↗ |
| Jul 28, 2021 | MTEM | 10% Owner | Purchase | 155.0K | $1.1M | SEC ↗ |
| Jul 21, 2021 | MTEM | 10% Owner | Purchase | 244.4K | $1.7M | SEC ↗ |
| Jun 23, 2021 | MGNX | 10% Owner | Purchase | 75.0K | $1.6M | SEC ↗ |
Showing the 25 most recent filings of 65. Screen every filing.
V N Biotech Target insider trading FAQ
Is V N Biotech Target buying or selling?
Across 65 SEC Form 4 filings, V N Biotech Target reported 64 open-market purchases totaling $164.9M and 1 sales totaling $845.8K — a net buying position of $164.0M.
Which companies does V N Biotech Target file Form 4s for?
V N Biotech Target has reported insider transactions at 4 companies, most often Molecular Templates, Inc. (MTEM), Esperion Therapeutics, Inc. (ESPR), MACROGENICS INC (MGNX), Radius Health, Inc. (RDUS).
How far back does V N Biotech Target's filing history go?
Trabud holds V N Biotech Target's SEC Form 4 filings from May 22, 2018 – Nov 19, 2024, sourced directly from SEC EDGAR.
Where does Trabud get V N Biotech Target's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track V N Biotech Target and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener